1 Min Read
April 28 (Reuters) - GENMAB A/S
* GENMAB ANNOUNCES NEW PHASE III COMBINATION STUDY OF DARATUMUMAB IN MULTIPLE MYELOMA
* STUDY EXPECTED TO START Q2 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.